Cargando…
No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment
To study the differences in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding (EVB) and renal functional impairment (RFI). METHODS: The National Health Insurance Database, part of the Taiwan National Health Insurance Program, was used...
Autores principales: | Hung, Tsung-Hsing, Tsai, Chen-Chi, Tseng, Chih-Wei, Tseng, Kuo-Chih, Hsieh, Yu-Hsi, Tsai, Chih-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams And Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051540/ https://www.ncbi.nlm.nih.gov/pubmed/27455080 http://dx.doi.org/10.1097/MEG.0000000000000703 |
Ejemplares similares
-
No Mortality Difference Following Treatment with Terlipressin or Somatostatin in Cirrhotic Patients with Gastric Variceal Hemorrhage
por: Hung, Tsung-Hsing, et al.
Publicado: (2016) -
High mortality of pneumonia in cirrhotic patients with ascites
por: Hung, Tsung-Hsing, et al.
Publicado: (2013) -
The long-term outcomes of cirrhotic patients with pleural effusion
por: Hung, Tsung-Hsing, et al.
Publicado: (2018) -
Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients With Hepatic Encephalopathy: A Population-Based 3-Year Follow-Up Study
por: Hung, Tsung-Hsing, et al.
Publicado: (2014) -
Endoscopic papillary balloon dilation decreases the risk of bleeding in cirrhotic patients compared with endoscopic biliary sphincterotomy: A national population-based study
por: Hung, Tsung-Hsing, et al.
Publicado: (2019)